Qualcomm Chip making company concept with main logo on the chip

Qualcomm Just Hit A 52 Week High—Time to Buckle Up

Qualcomm Chip making company concept with main logo on the chip

Qualcomm Inc. (NASDAQ: QCOM) stock has just had the kind of day many investors can only dream of. Having rarely gained more than 2% or 3%, shares jumped 11% on Monday, Oct. 28, to close around $187 in recent months, even on its better days. They had been up more than 20% at one point, marking their biggest single-day gain in years. The move came on the back of news that Qualcomm is entering the AI accelerator market, positioning itself to compete directly with NVIDIA Corp (NASDAQ: NVDA) and Advanced Micro Devices Inc (NASDAQ: AMD).

Qualcomm has lived in those giants’ shadow for years, despite consistently outperforming earnings expectations and trading at a comparatively cheap valuation. This latest development should finally change that dynamic. However, with gains of 70% already under its belt since this rally began in April, how should investors play it? Let’s take a closer look at the options. 

Why This Qualcomm Rally Could Be Different This Time

It must be acknowledged that Monday’s pop was more than just another headline-driven spike. Qualcomm’s entrance into the AI accelerator market represents a fundamental evolution of its business model. Until now, the company’s identity has been anchored in mobile chips and wireless technologies. That segment remains strong, but investors have long wanted proof that Qualcomm could diversify beyond smartphones.

The new strategy does precisely that. Qualcomm is positioning itself as a serious contender in the next wave of AI infrastructure by targeting the same high-performance computing market that has powered NVIDIA's meteoric rise. The timing could hardly be better. Investors have been searching for credible alternatives to the few dominant names driving the AI wave, and Qualcomm’s announcement has arrived not a moment too late.

What makes this rally different from previous false starts is its foundation. The stock’s uptrend since April has been orderly and consistent, with the bulls repeatedly stepping in to buy up any dips. Monday’s surge amplified that strength, setting Qualcomm up for its first sustained breakout in a long time.

But the market has a short memory. Qualcomm has sparked excitement before, only to fade when execution fell short. This time, the pressure is on to prove this isn’t another short-lived surge.

Bullish Analysts See Upside, Highlight Qualcomm’s Strengths

Wall Street’s reaction reflects that tension. On the bullish side, both Susquehanna and Weiss Ratings reaffirmed their Buy ratings last week, even before the latest update, pointing to the company’s solid fundamentals, diversified revenue base, and expanding AI exposure. Their price targets, ranging up to $200, imply additional upside from current levels and suggest confidence in Qualcomm’s execution.

But not everyone is entirely convinced. Also on Monday, the team at UBS Group reaffirmed their Neutral rating on the stock, along with a $165 target. The Bernstein team was also somewhat cautious, suggesting Qualcomm didn’t provide enough information to accurately forecast the impact of the new line of AI chips. 

The proximity of next week’s earnings report adds to the uncertainty. Qualcomm has built a reliable record of exceeding expectations, but the bar has been raised after such a dramatic move. Any weakness in established business units or less-than-confident remarks about its new chips could spook investors. 

2 Investment Paths for Qualcomm: Aggressive or Cautious?

For those of us on the sidelines, there are two clear ways to think about the opportunity from here. The first is the aggressive play: buy into the long-term vision and back the company to deliver another strong earnings update next week. Qualcomm’s valuation still looks modest relative to peers, and if it once again beats expectations and provides bullish forward guidance, a push through $200 could come fast.

The second is the cautious approach and waiting for confirmation from the earnings report. In the context of Qualcomm's track record, the stock’s 70% rally since April has been extraordinary. For all the enthusiasm around AI, Qualcomm has a long history of struggling to sustain momentum once excitement fades. Waiting to see how management frames its AI strategy, and whether the numbers back the optimism, may save latecomers from buying at the top.

Learn more about QCOM

Newest Stories

Innovation concept. Silhouette of drone flying on sunset. Heavy lift drone photographing
The Drone Arms Race: From Battlefield to Balance Sheet

Explosive, triple-digit gains in the stock market often trigger warnings and fears of a speculative bubble. The recent performance of the drone sector (a subset of the aerospace sector), where companies have seen their valuations soar to angelic flight levels, is no exception. While caution is alw...

Jeffrey Neal Johnson | Oct 28, 2025

green money arrows pointing higher
Why Wall Street Is Backing These 3 Comeback Stocks

A company's comeback story can mean a significant opportunity for investors to win returns in the financial world. Of course, when a stock has shed a sizable portion of its value in recent memory, many investors prefer to exercise caution unless there is a clear signal that the firm's fortunes cou...

Nathan Reiff | Oct 28, 2025

Intel logo graphic
Intel's Breakout Quarter: More Than a Beat, It's a Declaration

The moments after an earnings release often tell a story, and for Intel Corporation (NASDAQ: INTC), the story on Oct. 23 and since then has been one of resounding validation. A powerful upward momentum in the stock followed Intel’s third-quarter report, sending shares to multi-ye...

Jeffrey Neal Johnson | Oct 28, 2025

Test tubes with liquid in chemical laboratory on blurred background
1 Trial, 2 Franchises: Zenas Stock Climbs on Landmark Data

A pivotal clinical development has sent Zenas BioPharma (NASDAQ: ZBIO) shares climbing higher, reshaping the company’s investment profile overnight. On Oct. 27, 2025, Zenas BioPharma’s stock price climbed by over 30% on exceptionally high trading volume, pushing its market capitaliza...

Jeffrey Neal Johnson | Oct 28, 2025

TickerTalk Unveils Real-Time Financial Insights and Breaking News!